|Articles|August 18, 2006

Education and CME Trends

35th Annual Clinical Meeting of Advancing Minimally Invasive Gynecology Worldwide (AAGL)Las Vegas, NV - November 2006

Tamer A. Seckin, MD
872 Fifth Avenue
New York, NY 10021-4953
USA
Phone: 212.988.1444
Fax: 212.988.1755
Email: tamer@deep.net
Accreditation Council for Gynecologic Endoscopy, Inc.

The file you requested will begin playing automatically. If it does not, press the 'play' button. If you experience playback problems, make certain you have the latest version of Windows Media Player, available here. If you have the latest Windows Media Player and still experience problems, email the Webmaster with a description of the problem and any error messages you may have received.

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related to this article

October 2nd, 2026

Contemporary OB/GYN's top expert interviews from September 2026

A recap of the top videos and podcasts from Contemporary OB/GYN in September 2026, featuring expert interviews on salpingectomy, testosterone evidence, and more.

October 1st, 2026

Top headlines in women's health from September 2026

A recap of the top headlines from Contemporary OB/GYN in September 2026, spanning ACOG's respiratory vaccine guidance to the launch of the Missed & Dismissed podcast.

October 1st, 2026

A recap of top FDA & regulatory news from September 2026

A recap of Contemporary OB/GYN's top FDA and regulatory news from September 2026.

September 30th, 2026

FAQ: What does the rename from PCOS to PMOS mean for your patients?

A global consensus published in The Lancet has officially renamed polycystic ovary syndrome to polyendocrine metabolic ovarian syndrome, a change with broad implications for diagnosis, care, and cardiometabolic screening.

September 28th, 2026

Missed & Dismissed: The diagnostic gap starts in childhood

In the debut episode of Missed & Dismissed, Calbeth C. Alaribe, DMSc, MPH, PA-C, CPCHE, talks with Charis Chambers, MD, about PCOS, the push to rename it PMOS, and why diagnostic delays so often begin in adolescence.

September 23rd, 2026

Sameena Rahman, MD, on bias, dismissed diagnoses, and the vulvar vestibule

A new book from Sameena Rahman, MD, reclaims "brown girls' disease" as a lens for examining how dismissal—of conditions, anatomy, and patients—undermines sexual medicine care for all women.

September 23rd, 2026

FDA approves IDE for pivotal study of Evident ovarian cancer screening test

The FDA approved an IDE allowing Mercy BioAnalytics to evaluate its Evident blood-based ovarian cancer screening test in the prospective pivotal SOARA study of average-risk women.